Bioness Medical, Inc. ("Bioness", or the "Company"), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies, today announced that the Company's PoNS® ...

What if chronic diseases, which are difficult to treat with medicine alone, could be managed with electricity? As "neuromodulation"—a technology that restores bodily balance by sending signals ...

In an article published in Brain Medicine, a European research team presents a focused review of emerging neuromodulation techniques for treatment-resistant obsessive-compulsive disorder (OCD). The ...

The FDA authorized marketing of the Portable Neuromodulation Stimulator (Pons) for short-term treatment of gait issues arising from mild to moderate symptoms associated with multiple sclerosis (MS) ...

Optimizing stimulation protocols for peripheral neuromodulation often depends on patient feedback, which can result in inconsistent clinical outcomes. Here we present a closed-loop control system for ...

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to ...

The U.S. Brain Implants Market is expected to reach USD 8.17 Billion by 2035, while Europe is projected to reach USD 4.63 ...

Neuromodulation of deep brain structures via transcranial ultrasound stimulation (TUS) is a promising, but still elusive approach to non-invasive treatment of brain disorders. The purpose of this ...

HOUSTON--(BUSINESS WIRE)--Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server ...

Helius Medical Technologies Inc (NASDAQ:HSDT) shares are trading higher after the Centers for Medicare & Medicaid Services assigned Healthcare Common Procedure Coding System (HCPCS) Level II codes ...